Goltermann N R, Stengaard-Pedersen K, Rehfeld J F, Christensen N J
J Neurochem. 1981 Mar;36(3):959-65. doi: 10.1111/j.1471-4159.1981.tb01687.x.
The subcellular localization of in vivo synthesized cholecystokinin (CCK) in different parts of the rat brain was studied after intracisternal pulse injections of [35S]methionine. The rats were decapitated 1 h after the injection, and the brain was divided into cortex, hippocampus and remainder. Subcellular fractions were obtained according to Whittaker's method. De novo synthesized CCK in the crude mitochondrial-synaptosomal fraction, P2, and in the purified synaptosomal fraction was demonstrated by affinity chromatography, using antibodies specific for the COOH-terminal sequence of CCK. By subsequent gel chromatography two molecular forms of labelled CCK occurred, with elution constants, Kav, of 1.1 (corresponding to the COOH-terminal octapeptide) and of 1.40 (a component which may correspond to the COOH-terminal tetrapeptide amide, CCK-4). The findings support the idea that the small molecular forms are the transmitter forms of CCK.
经脑池内脉冲注射[35S]蛋氨酸后,研究了大鼠脑不同部位体内合成的胆囊收缩素(CCK)的亚细胞定位。注射后1小时将大鼠断头,将脑分为皮质、海马和其余部分。根据惠特克方法获得亚细胞组分。使用针对CCK羧基末端序列的特异性抗体,通过亲和色谱法证明了粗线粒体-突触体组分P2和纯化的突触体组分中从头合成的CCK。随后通过凝胶色谱法出现了两种标记CCK的分子形式,洗脱常数Kav分别为1.1(对应于羧基末端八肽)和1.40(一种可能对应于羧基末端四肽酰胺,CCK-4的组分)。这些发现支持小分子形式是CCK的递质形式这一观点。